Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

The CONSENSUS study: protocol for a mixed methods study to establish which outcomes should be included in a core outcome set for oropharyngeal cancer

Authors: Aoife MI Waters, Catrin Tudur Smith, Bridget Young, Terry M Jones

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

The incidence of oropharyngeal cancer is increasing in the developed world. This has led to a large rise in research activity and clinical trials in this area, yet there is no consensus on which outcomes should be measured. As a result, the outcomes measured often differ between trials of comparable interventions, making the combination or comparison of results between trials impossible. Outcomes may also be ‘cherry-picked’, such that favourable results are reported, and less favourable results withheld. The development of a minimum outcome reporting standard, known as a core outcome set, goes some way to addressing these problems. Core outcome sets are ideally developed using a patient-centred approach so that the outcomes measured are relevant to patients and clinical practice. Core outcome sets drive up the quality and relevance of research by ensuring that the right outcomes are consistently measured and reported in trials in specific areas of health or healthcare.

Methods/Design

This is a mixed methods study involving three phases to develop a core outcome set for oropharyngeal cancer clinical trials. Firstly, a systematic review will establish which outcomes are measured in published oropharyngeal cancer randomised controlled trials (RCTs). Secondly, qualitative interviews with patients and carers in the UK and the USA will aim to establish which outcomes are important to these stakeholders. Data from these first two stages will be used to develop a comprehensive list of outcomes to be considered for inclusion in the core outcome set. In the third stage, patients and clinicians will participate in an iterative consensus exercise known as a Delphi study to refine the contents of the core outcome set. This protocol lays out the methodology to be implemented in the CONSENSUS study.

Discussion

A core outcome set defines a minimum outcome reporting standard for clinical trials in a particular area of health or healthcare. Its consistent implementation in oropharyngeal cancer clinical trials will improve the quality and relevance of research.

Trials and registration

This study is registered at the National Institute for Health Research (NIHR) Clinical Research Network (CRN) portfolio, ID 13823 (17 January 2013).
Literature
1.
2.
Price G, Roche M, Crowther R, Wright R: Profile of head and neck cancers in England: incidence, mortality and survival. 2010, Oxford: Oxford Cancer Intelligence Unit
3.
Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML: Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013, 31 (36): 4550-4559. 10.1200/JCO.2013.50.3870.CrossRefPubMedPubMedCentral
4.
Shaw R, Robinson M: The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. Br J Oral Maxillofac Surg. 2011, 49 (6): 423-429. 10.1016/j.bjoms.2010.06.023.CrossRefPubMed
5.
Ragin CCR, Taioli E: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Canc. 2007, 121 (8): 1813-1820. 10.1002/ijc.22851.CrossRef
6.
Sinha IP, Smyth RL, Williamson PR: Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011, 8 (1): e1000393-10.1371/journal.pmed.1000393.CrossRefPubMedPubMedCentral
7.
Kirkham J, Boers M, Tugwell P, Clarke M, Williamson P: Outcome measures in rheumatoid arthritis randomised trials over the last 50 years. Trials. 2013, 14 (1): 324-10.1186/1745-6215-14-324.CrossRefPubMedPubMedCentral
8.
Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L: OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials. 2007, 8 (1): 38-10.1186/1745-6215-8-38.CrossRefPubMedPubMedCentral
9.
Kirwan JR, de Wit M: What have we learned from a decade of patient involvement in OMERACT and its effect on trial outcome assessments?. Trials. 2011, 12 (Suppl 1): A80-10.1186/1745-6215-12-S1-A80.CrossRefPubMedCentral
10.
Denegri S, Buckland S: INVOLVE response to Commons Select Committee Inquiry into clinical trials. 2013, Eastleigh: INVOLVE
11.
Sanders C, Egger M, Donovan J, Tallon D, Frankel S: Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ. 1998, 317 (7167): 1191-1194. 10.1136/bmj.317.7167.1191.CrossRefPubMedPubMedCentral
12.
Calvert M, Brundage M, Jacobsen P, Schunemann H, Efficace F: The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice. Health Qual Life Outcomes. 2013, 11 (1): 184-10.1186/1477-7525-11-184.CrossRefPubMedPubMedCentral
13.
Williamson P, Clarke M: The COMET (Core Outcome Measures in Effectiveness Trials) initiative: its role in improving cochrane reviews. Cochrane Database Syst Rev. 2012, 5: ED000041-PubMed
14.
Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P: Developing core outcome sets for clinical trials: issues to consider. Trials. 2012, 13 (1): 132-10.1186/1745-6215-13-132.CrossRefPubMedPubMedCentral
15.
Tschiesner U, Rogers S, Dietz A, Yueh B, Cieza A: Development of ICF core sets for head and neck cancer. Head Neck. 2010, 32 (2): 210-220.PubMed
16.
Coyne IT: Sampling in qualitative research: purposeful and theoretical sampling; merging or clear boundaries?. J Adv Nurs. 1997, 26 (3): 623-630. 10.1046/j.1365-2648.1997.t01-25-00999.x.CrossRefPubMed
17.
Molina MA, Cheung MC, Perez EA, Byrne MM, Franceschi D, Moffat FL, Livingstone AS, Goodwin WJ, Gutierrez JC, Koniaris LG: African American and poor patients have a dramatically worse prognosis for head and neck cancer. Cancer. 2008, 113 (10): 2797-2806. 10.1002/cncr.23889.CrossRefPubMed
18.
Catherine P, Sue Z, Nicholas M: Analysing qualitative data. BMJ. 2000, 320 (7227): 114-116. 10.1136/bmj.320.7227.114.CrossRef
19.
Glaser BG: The constant comparative method of qualitative analysis. Soc Probl. 1965, 12 (4): 436-445. 10.2307/798843.CrossRef
20.
Polkinghorne DE: Narrative configuration in qualitative analysis. Int J Qual Stud Educ. 1995, 8 (1): 5-23. 10.1080/0951839950080103.CrossRef
21.
Dalkey N, Helmer O: An experimental application of the Delphi method to the use of experts. Manag Sci. 1963, 9 (3): 458-467. 10.1287/mnsc.9.3.458.CrossRef
22.
Jaeschke R, Guyatt GH, Dellinger P, Schünemann H, Levy MM, Kunz R, Norris S, Bion J, GRADE Working Group: Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008, 337: a744-10.1136/bmj.a744.CrossRefPubMed
23.
GRADE handbook for grading quality of evidence and strength of recommendation. Edited by: Oxman, Schünemann H, Brozek J. 2009, Version 3.2. The GRADE Working Group
24.
Skulmoski GJ, Hartman FT, Krahn J: The Delphi method for graduate research. J Inf Technol Educ. 2007, 6: 1-21.
25.
Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Care Res. 2008, 59 (7): 952-960. 10.1002/art.23826.CrossRef
26.
Macefield R, Blencowe N, Brookes S, Jacobs M, Sprangers M, Williamson P, Blazeby J: Core outcome set development: the effect of Delphi panel composition and feedback on prioritisation of outcomes. Trials. 2013, 14 (Suppl 1): 77-CrossRef
27.
Goodman CM: The Delphi technique: a critique. J Adv Nurs. 1987, 12 (6): 729-734. 10.1111/j.1365-2648.1987.tb01376.x.CrossRefPubMed
Metadata
Title
The CONSENSUS study: protocol for a mixed methods study to establish which outcomes should be included in a core outcome set for oropharyngeal cancer
Authors
Aoife MI Waters
Catrin Tudur Smith
Bridget Young
Terry M Jones
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-168

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue

Research

Grip on challenging behavior: process evaluation of the implementation of a care program

Commentary

Five questions that need answering when considering the design of clinical trials

Research

Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: preliminary findings of the Canola Oil Multicenter Intervention Trial (COMIT)

Study protocol

Effectiveness of adolescent suicide prevention e-learning modules that aim to improve knowledge and self-confidence of gatekeepers: study protocol for a randomized controlled trial

Study protocol

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial

Study protocol

Impact of early enteral versus parenteral nutrition on mortality in patients requiring mechanical ventilation and catecholamines: study protocol for a randomized controlled trial (NUTRIREA-2)